← FDA Drug Approvals (Drugs@FDA)
POTASSIUM PHOSPHATES
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2025-01-24
Drug application
- FDA Application #
ANDA217892- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- POTASSIUM PHOSPHATES
- Generic name
- POTASSIUM PHOSPHATES
- Active ingredients
- POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- CIPLA
- Manufacturer
- Cipla USA Inc.
- First approval
- 2025-01-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown